Development of multiple cutaneous immune-related adverse events among cancer patients after immune checkpoint blockade: Supplemental File
Published: 14 June 2022| Version 1 | DOI: 10.17632/r4bsshkm6w.1
Edward Christopher Dee,
This file discusses additional methodological details and includes a supplemental table summarizing cirAE characteristics in patients who developed multiple cirAEs after ICI therapy.
Oncology, Dermatological Disease, Adverse Event, Medical Dermatology, Immune Checkpoint Blockade